Piyong swore that it was not about Director Wu.
Jiang Wei didn't force her to die, she was sworn to, so she comforted her with words and didn't want to offend her friend.
However, she still said some tough words on behalf of Liu Miqiao.
She said: "Pi Yong, you are Liu Miqiao's friend who has known him for half a year, and you drink too much tea. If you want me or Liu Miqiao to do something, logically, we should help you do it. However, everyone has their own problems.
Bottom line, everyone has scars in their heart. Don't expose Liu Miqiao's scars. The first setback he encountered when he entered this society was from Director Wu and others. As for Director Wu, Liu Miqiao said, for your sake
In terms of face, he would not stab him secretly. As for whether they can pass the assessment, that is the cause and effect of their normal actions, no one can blame them. However, we Liu Maqiao will not be villains, and we will do everything above board. As for Director Wu,
Hope for cooperation, Liu Muqiao said that he will not cooperate with others within three years..."
When Jiang Wei reached this point, Pi Yong knew that there was no chance.
However, there is also something to gain. Since Liu Muqiao promised not to stab Wu Chu, he can almost do the job.
Pi Yong found Wu Chu and modified Liu Miqiao's words.
"Wu Chu, during this period, I tried my best to use money. It was a trivial matter. I just found things that Liu Miqiao and his girlfriend liked. I went from Xing'an Mountains to Banna, then to South America, and finally to Africa. Finally, Liu Miqiao
I personally promised one thing that he will not mess with you, and he will also say a few good words for you to make you feel at ease. As for other people, there is nothing I can do."
He didn't say much, but Wu Chu was sweating coldly after hearing it.
To be honest, according to the recent analysis of the situation in the office, Liu Muqiao is not a little bit harmful. He is probably a very powerful person. It would be too easy to just say a few words and get a few people.
Now, Liu Muqiao agrees to treat him differently, and he is half relieved.
Set this aside in advance.
A group of them don’t dare to say anything is wrong with Liu Muqiao. He just doesn’t seek your cooperation and doesn’t want your money. Can you say that he is wrong?
……
Liu Muqiao published 5 papers in "China" magazine.
One article is "Observation of the Efficacy of New Stroke Therapies" co-authored by Liu Miqiao, Zou Qingxiang, and Zhao Yilin. It is a comprehensive evaluation of stroke treatment. It is very shocking. They are going for the international award. If the selection is fair, the Nobel Prize will be awarded.
The hope is very high.
It summarizes various treatment methods such as minimally invasive puncture, "Huatuo Regeneration Pill" treatment, brainstem puncture, etc. The case summarized is a patient.
12,000 is a very large number and the credibility is very high.
The second paper was "Study on the Efficacy of Spinal Anastomosis". He collaborated with Zhu Yaguang, Tang Hui, and He Yuanming, and later added Song Baibai when submitting the paper.
This is another great achievement, and it is also aimed at the grand prize.
This article can be said to be of Kaiyuan nature, with a large number of cases, 134, of which 92% were significant and 8% were good.
Almost every case is successful.
The possibility of winning the Nobel Prize is relatively small, but the chance of winning the subject award or the national award is very high, and it is almost certain that you will win the award.
The third article was written in the name of Liu Muqiao alone, "Application of Minimally Invasive Puncture Technology in the Treatment of Primary Epilepsy".
This is also a very shocking paper.
It opens up new ways to treat epilepsy.
However, the method described in this paper has very little reproducibility.
The reason is very simple. First, the surgeon's imaging ability cannot reach the level of Liu Muqiao, and secondly, the puncture ability cannot be as good as Liu Muqiao.
This article is enough for Liu Miqiao to establish the image of a "god".
The fourth article is "Exploration of the Efficacy of Vilishi Modified Surgery and Ketu No. 1 for Pancreatic Cancer" written by Liu Muqiao, Du Xiaoping, and Meng Feiyun.
This is a small paper. However, it contains an important message. The key is not the improved technique, but the efficacy of "Ke Tu No. 1".
So far, no one who has used Keliu No. 1 has experienced metastasis or recurrence. As time goes by, will there be a miracle?
If it is a new anti-cancer drug with high efficacy, then this paper will surpass all previous results.
The fifth paper is "Discussion of Traditional Chinese Medicine in the Treatment of Depression" co-written with Su Yajuan.
Although it is not a big paper, it can be said that it echoes the previous two papers and explains the important role of traditional Chinese medicine.
There are also papers to be published in the next issue. There are many things to summarize and there are many papers to write.
Director Yuan and Dr. A Ling of Pediatrics are both writing.
Su Yajuan is writing a summary of the efficacy of special wound treatment.
Qin Meixiang is writing about the manual reduction of cervical spondylosis and lumbar disc herniation.
Xu Fansheng is writing a summary of surgical treatment of intestinal diseases.
Hua Bucheng is not idle either.
Wait.
As soon as these five masterpieces were published, they quickly sold out.
"China" magazine suddenly became popular.
So red it turns purple.
It is impossible for this phenomenon not to be noticed by famous journals such as "The Lancet".
Liu Muqiao suddenly published a large number of papers. Others don’t know the reason. It’s impossible for them not to know.
Here Liu Muqiao is promoting the "China" journal.
"Hey! It's incredible. The journal "China" is about to rise. It's so popular that there's no way to suppress it!"
The bosses of several major journals exclaimed in unison.
Indeed, these five papers are so important, they are all papers that will win big awards in the future!
As a general rule, most of the papers that win awards are from the "top ten journals". Now, the "China" journal will not only be ranked among the top ten journals, but may also be ranked among the top three.
The key is that Liu Muqiao's papers are all groundbreaking.
From now on, other people’s papers will cite Liu Miqiao’s data.
This is terrible.
The impact factor of the "China" journal will be greatly improved.
Will there be a second wave of Liu Muqiao?
Their intelligence system soon told them a terrifying data.
Liu Muqiao will publish 5 papers every month.
This is too scary.
The information collected by their intelligence system is correct. Liu Muqiao has arranged the task of writing papers for the first half of this year. With him as the first author, there will be 5 papers per month. The amount seems scary, but there is really too much material to be mined.
Let alone half a year, there will be no problem if this continues for a long time.
At this time, the country is organizing a review. Last year's Science and Technology Achievement Award will be judged in the first half of the year.
There are a total of 6 scientific and technological achievements submitted by Qingjiang University for review, of which Liu Miqiao's accounted for two.
Liu Muqiao submitted for review "New Progress in Stroke Treatment" and "Technical Innovation in Spinal Anastomosis".
They are all heavyweights.
In addition, Zhou Ming also has a scientific research result that he submitted for review, which is "New Technology for Refining Rare Earths". This is also a scientific research result that can win awards.
This chapter has been completed!